Evidence map›Paper›PMID 40322610›Full record

ArticleCureus2025

Prognostic Factors and Imaging Strategies in Unknown Subarachnoid Hemorrhage: A Retrospective Study.

Monami Dai, Kimura Tatsuki, Shunsuke Ikeda, Taro Yanagawa, Shinichiro Yoshikawa, Tsuyoshi Uesugi, Toshiki Ikeda

Abstract read
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Monami DaiStroke Center, Sagamihara Kyodo Hospital, Sagamihara, JPN.
Kimura TatsukiStroke Center, Sagamihara Kyodo Hospital, Sagamihara, JPN.
Shunsuke IkedaStroke Center, Sagamihara Kyodo Hospital, Sagamihara, JPN.
Taro YanagawaStroke Center, Sagamihara Kyodo Hospital, Sagamihara, JPN.
Shinichiro YoshikawaStroke Center, Sagamihara Kyodo Hospital, Sagamihara, JPN.
Tsuyoshi UesugiStroke Center, Sagamihara Kyodo Hospital, Sagamihara, JPN.
Toshiki IkedaStroke Center, Sagamihara Kyodo Hospital, Sagamihara, JPN.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background Subarachnoid hemorrhage (SAH) without an identifiable vascular lesion on initial angiography, commonly referred to as unknown or angiogram-negative SAH, remains diagnostically and prognostically challenging. Although perimesencephalic patterns tend to be benign, diffuse hemorrhages are associated with worse outcomes. The role of repeat vascular imaging in improving diagnosis and predicting prognosis remains unclear. Objective This study aimed to identify clinical and radiological factors associated with outcomes in patients with unknown SAH and evaluate the diagnostic and prognostic value of repeat angiography. Methods We retrospectively analyzed 26 patients with spontaneous, non-traumatic SAH and negative findings on initial digital subtraction angiography (DSA). Clinical status, hemorrhage patterns, and imaging data were recorded. Outcomes were assessed at discharge using the modified Rankin Scale (mRS). Repeat angiographic modalities and timing were analyzed in relation to prognosis. Results Patients with focal hemorrhage patterns, higher Glasgow Coma Scale (GCS) scores at admission, and absence of hydrocephalus had significantly better outcomes. Repeat DSA was more frequently performed in the good outcome group, although no new vascular lesions were identified.  Conclusion Unknown SAH is generally associated with favorable outcomes, but vigilance is warranted in diffuse SAH cases. Repeat DSA may not always reveal new lesions, but it plays a valuable role in guiding clinical confidence and management decisions. Tailored imaging strategies based on clinical and radiological risk factors are recommended.

Indexed as

angiographydiagnosisdsasahunknown sah

Identifiers

PMID40322610
PMCPMC12049161

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.